MediWound Ltd. (MDWD)
13.65
-0.03
(-0.22%)
USD |
NASDAQ |
Nov 18, 16:00
13.65
0.00 (0.00%)
After-Hours: 20:00
MediWound Enterprise Value : 158.09M for Nov. 17, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 158.09M |
| November 16, 2026 | 156.41M |
| November 13, 2026 | 148.02M |
| November 12, 2026 | 148.92M |
| November 11, 2026 | 159.89M |
| November 10, 2026 | 163.64M |
| November 09, 2026 | 163.25M |
| November 06, 2026 | 165.44M |
| November 05, 2026 | 153.57M |
| November 04, 2026 | 164.80M |
| November 03, 2026 | 154.34M |
| November 02, 2026 | 155.76M |
| October 30, 2026 | 153.18M |
| October 29, 2026 | 160.41M |
| October 28, 2026 | 156.54M |
| October 27, 2026 | 143.50M |
| October 26, 2026 | 137.24M |
| October 23, 2026 | 136.40M |
| October 22, 2026 | 138.72M |
| October 21, 2026 | 137.69M |
| October 20, 2026 | 137.69M |
| October 19, 2026 | 145.43M |
| October 16, 2026 | 134.46M |
| October 15, 2026 | 139.11M |
| October 14, 2026 | 135.23M |
| Date | Value |
|---|---|
| October 13, 2026 | 139.24M |
| October 12, 2026 | 143.63M |
| October 09, 2026 | 143.37M |
| October 08, 2026 | 141.82M |
| October 07, 2026 | 147.37M |
| October 06, 2026 | 151.24M |
| October 05, 2026 | 155.89M |
| October 02, 2026 | 156.02M |
| October 01, 2026 | 157.05M |
| September 30, 2026 | 159.25M |
| September 29, 2026 | 152.36M |
| September 28, 2026 | 154.04M |
| September 25, 2026 | 152.87M |
| September 24, 2026 | 152.75M |
| September 23, 2026 | 150.42M |
| September 22, 2026 | 154.29M |
| September 21, 2026 | 146.03M |
| September 18, 2026 | 147.19M |
| September 17, 2026 | 146.55M |
| September 16, 2026 | 144.87M |
| September 15, 2026 | 148.10M |
| September 14, 2026 | 153.39M |
| September 11, 2026 | 143.45M |
| September 10, 2026 | 151.20M |
| September 09, 2026 | 152.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 62.64B |
| RedHill Biopharma Ltd. | -11.74M |
| Purple Biotech Ltd. | -3.262M |
| Sol-Gel Technologies Ltd. | 129.48M |
| PolyPid Ltd. | 123.72M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.987M |
| Revenue (Quarterly) | 3.573M |
| Total Expenses (Quarterly) | 9.56M |
| EPS Diluted (Quarterly) | -0.4617 |
| Gross Profit Margin (Quarterly) | 28.46% |
| Profit Margin (Quarterly) | -167.6% |
| Earnings Yield | -13.37% |
| Normalized Earnings Yield | -13.37 |